SGNI StemGen

StemGen, Inc (the “Company”) was incorporated in Delaware in 1992, and in 1996 received all remaining assets of Infotechnology, Inc. (“Infotech”), a Delaware company, following the completion of Infotech’s Chapter 11 Bankruptcy reorganization, in accordance with an Assignment and Assumption Agreement, dated October 11, 1996, and effective as of June 21, 1996. As a result of a series of transactions during the 1980’s, Infotech, then principally engaged in the information and communications business, acquired equity interests in Comtex News Network, Inc. (“Comtex”) and Analex Corporation (“Analex”), formerly known as Hadron, Inc. Our business was the maintenance of our equity interest in and note receivable from Comtex and equity interest in Analex.
Company profile
Ticker
SGNI
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • Activision Blizzard • BlackBerry • NortonLifeLock • Adobe • Vmware • Ceridian HCM Holding • McAfee • SolarWinds ...
Former names
AMASYS CORP
SEC CIK
Corporate docs
IRS number
541812385
Press releases
StemGen Announces Pilot Program for D3eSports Cup Powered by StemGen Educational Tournament Completed
31 Mar 21
StemGen Announces New 2021 D3eSports Corporate Cup ESports Series and International Circuits
26 Feb 21
StemGen Announces D3eSports Cup Powered by StemGen Educational STEM Pilot Program
11 Feb 21
StemGen Announces Impressive Executive Management Team
4 Feb 21
StemGen Announces Ian Dawson to Lead Energy Division
26 Jan 21
Calendar
22 Feb 21
11 Apr 21
30 Jun 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Jun 20 | Jun 19 | Jun 18 | Jun 15 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from StemGen earnings reports.
Financial report summary
?Management Discussion
- For the fiscal year ended June 30, 2020, the Company had a net loss of $230,772 and negative cash flow from operations of $36,525. As of June 30, 2020, the Company has negative working capital of $1,461,648.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
sale
Removed:
transition
Financial reports
10-Q
2021 Q2
Quarterly report
22 Feb 21
NT 10-Q
Notice of late quarterly filing
17 Feb 21
10-Q
2021 Q1
Quarterly report
16 Nov 20
10-K
2020 FY
Annual report
8 Oct 20
NT 10-K
Notice of late annual filing
29 Sep 20
10-Q
2020 Q3
Quarterly report
10 Jun 20
10-Q/A
2020 Q2
Quarterly report (amended)
14 May 20
10-Q
2020 Q2
Quarterly report
27 Feb 20
NT 10-Q
Notice of late quarterly filing
18 Feb 20
10-Q
2020 Q1
Quarterly report
18 Dec 19
Current reports
8-K
Stemgen Announces Impressive Excutive Management Team
8 Feb 21
8-K
Changes in Registrant's Certifying Accountant
19 Mar 20
8-K
Changes in Registrant's Certifying Accountant
3 Mar 20
8-K
Entry into a Material Definitive Agreement
21 May 19
8-K/A
Entry into a Material Definitive Agreement
15 Feb 19
8-K/A
Entry into a Material Definitive Agreement
1 Feb 19
8-K
Entry into a Material Definitive Agreement
19 Dec 18
8-K
Departure of Directors or Certain Officers
28 Feb 18
8-K
Changes in Registrant's Certifying Accountant
19 Oct 17
8-K
Unregistered Sales of Equity Securities
12 Mar 15
Registration and prospectus
S-1/A
IPO registration (amended)
28 Jul 20
S-1/A
IPO registration (amended)
14 Jul 20
S-1/A
IPO registration (amended)
23 Jun 20
S-1/A
IPO registration (amended)
14 May 20
S-1
IPO registration
7 Jan 20
RW
Registration withdrawal request
19 Nov 15
S-1/A
2015 FY
IPO registration (amended)
18 Oct 15
S-1/A
IPO registration (amended)
19 Jul 15
S-1/A
2015 Q2
IPO registration (amended)
26 Apr 15
S-1
IPO registration
16 Mar 15
Other
EFFECT
Notice of effectiveness
31 Jul 20
CORRESP
Correspondence with SEC
28 Jul 20
CORRESP
Correspondence with SEC
28 Jul 20
CORRESP
Correspondence with SEC
13 Jul 20
UPLOAD
Letter from SEC
5 Jul 20
CORRESP
Correspondence with SEC
22 Jun 20
UPLOAD
Letter from SEC
27 May 20
CORRESP
Correspondence with SEC
14 May 20
UPLOAD
Letter from SEC
20 Jan 10
CORRESP
Correspondence with SEC
10 Jan 10